These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8508993)

  • 21. [Peripheric artery diseases. Systemic character of atherothrombosis needs a systemic approach to therapy].
    Kandykin VV
    Klin Khir; 2000 Oct; (10):55-9. PubMed ID: 11247439
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute arterial occlusion of the extremities. Emergency measures in general practice and conservative therapy].
    Hasse HM
    Verh Dtsch Ges Inn Med; 1972; 78():551-4. PubMed ID: 4665692
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines for therapeutic studies in Fontaine's stages II-IV peripheral arterial occlusive disease. German Society of Angiology.
    Heidrich H; Cachovan M; Creutzig A; Rieger H; Trampisch HJ
    Vasa; 1995; 24(2):107-19. PubMed ID: 7793141
    [No Abstract]   [Full Text] [Related]  

  • 24. Critical issues in peripheral arterial disease detection and management: a call to action.
    Belch JJ; Topol EJ; Agnelli G; Bertrand M; Califf RM; Clement DL; Creager MA; Easton JD; Gavin JR; Greenland P; Hankey G; Hanrath P; Hirsch AT; Meyer J; Smith SC; Sullivan F; Weber MA;
    Arch Intern Med; 2003 Apr; 163(8):884-92. PubMed ID: 12719196
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of physical therapy in peripheral arterial occlusive diseases. I].
    Krause D; Dittmar K
    Munch Med Wochenschr; 1973 Mar; 115(11):438-40. PubMed ID: 4740052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rational approach to peripheral arterial occlusive disease. Correcting pressure properly].
    Wepner U
    MMW Fortschr Med; 2004 Feb; 146(7):4-6, 8. PubMed ID: 15347040
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is obliterating arteriopathy of the lower limbs still the poor member of the arterial disease family? What can be done?].
    Blacher J
    J Mal Vasc; 2007 Apr; 32(2):73-4. PubMed ID: 17498900
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angioplasty of atheromatous hemodynamic stenoses of intracranial vertebral arteries].
    Kubis N; Houdart E; Merland JJ; Gaston A; Pinel JF; Haguenau M; Woimant F
    Rev Neurol (Paris); 1997 Jul; 153(6-7):386-92. PubMed ID: 9684004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct PTCA vs. sequential thrombolytic PTCA therapy in acute myocardial infarction: a retrospective analysis.
    Beauchamp G
    J Invasive Cardiol; 1991; 3(Suppl A):55A-9A. PubMed ID: 10149125
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppurative bacterial endarteritis after percutaneous transluminal angioplasty, stenting and thrombolysis for femoropopliteal arterial occlusive disease.
    Giannoukas DD; Tsetis DK; Touloupakis E; Alamanos E; Karniadakis S; Korakas P; Katsamouris AN
    Eur J Vasc Endovasc Surg; 1999 Nov; 18(5):455-7. PubMed ID: 10610837
    [No Abstract]   [Full Text] [Related]  

  • 31. [Disease-specific Questionnaire for Quality of Life in Patients with Peripheral Arterial Occlusive Disease in the Stage of Critical Ischemia (FLeQKI)--methodical development of a specific measuring instrument and psychometric evaluation of its validity and reliability (Part 1)].
    Wohlgemuth WA; Olbricht W; Klarmann S; Engelhardt M; Freitag MH; Wölfle K; Bohndorf K; Kirchhof K
    Rofo; 2007 Dec; 179(12):1251-7. PubMed ID: 18004695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished response to activated protein C is not correlated with severity of peripheral arterial occlusive disease.
    Köppel H; Renner W; Krippl P; Wascher TC; Pilger E
    Clin Lab; 2004; 50(11-12):689-93. PubMed ID: 15575311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute arterial occlusive disease].
    Ishimaru S; Uchino T
    Ryoikibetsu Shokogun Shirizu; 1996; (14):447-50. PubMed ID: 9047900
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of physical therapy in peripheral arterial circulatory diseases (author's transl)].
    Krause D; Dittmar K
    Munch Med Wochenschr; 1973 Oct; 115(40):1742-4. PubMed ID: 4801041
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comments on guidelines for therapeutic studies in Fontaine's stage II-IV peripheral arterial occlusive disease].
    Heidrich H; Trampisch HJ; Roehmel J
    Vasa; 1996; 25(1):73-5. PubMed ID: 8851269
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral arterial occlusive disease, Part I: Navigating a bottleneck.
    Rice KL; Walsh ME
    Nursing; 1998 Feb; 28(2):33-8; quiz 45. PubMed ID: 9496078
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guidelines for evaluating therapy studies in Fontaine stages II-IV of peripheral arterial occlusive disease by H. Heidrich et. al].
    Staehelin-Bossard A
    Vasa; 1993; 22(2):188-9. PubMed ID: 8322508
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current internal therapy in arterial occlusive diseases].
    Marshall M
    ZFA (Stuttgart); 1980 Sep; 56(26):1625-33. PubMed ID: 7456655
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinolytic, revascularizing therapy of peripheral arterial occlusive disease].
    Altmann E; Stelzner C; Graf A
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):651-8. PubMed ID: 10666829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.